WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kyle PiskelChief Financial Officer2025-05-161,929$8.89
$17.15kSell
Kyle PiskelChief Financial Officer2025-05-161,929$8.89
$17.15kSell
Harlan S. RobinsChief Scientific Officer2025-05-0168,412$7.35
$502.83kSell
Harlan S. RobinsChief Scientific Officer2025-05-0168,412$6.32
$432.36kBuy
Harlan S. RobinsChief Scientific Officer2025-03-241,698$6.32
$10.73kBuy
Harlan S. RobinsChief Scientific Officer2025-03-241,698$9.00
$15.28kSell
Kyle PiskelChief Financial Officer2025-03-142,500$6.32
$15.80kBuy
Michelle Renee GriffinDirector2025-03-1336,291$7.19
$260.93kSell
Robert HershbergDirector2025-03-1253,000$7.59
$402.27kSell
Peter M. NeupertDirector2025-03-1050,000$4.07
$203.50kBuy

1 of 4

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC20.35%30,993,708$552.62MInsider
Viking Global Investors LP19.70%29,993,708$534.79MInsider
Viking Global Investors LP19.70%29,993,708$534.79MInstitution
Blackrock Inc8.98%13,666,850$243.68MInstitution
David E. Goel8.08%12,310,594$219.50MInsider
Vanguard Group Inc7.41%11,279,195$201.11MInstitution
Chad M. Robins4.20%6,396,749$114.05MInsider
Rubric Capital Management LP4.11%6,256,847$111.56MInstitution
Sumitomo Mitsui Trust Group Inc2.82%4,299,684$76.66MInstitution
Nikko Asset Management Americas Inc2.82%4,299,684$76.66MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT62.48%37.52%Net Selling
RXRX71.45%16.05%Net SellingNet Selling
CPRX82.76%15.97%Net BuyingNet Buying
FOLD66.49%33.51%Net SellingNet Selling
SRRK61.10%38.90%Net SellingNet Buying
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 97.31% institutional shareholders, 58.44% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 20.35% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $537.74M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.